Literature DB >> 20448040

The B56gamma3 regulatory subunit of protein phosphatase 2A (PP2A) regulates S phase-specific nuclear accumulation of PP2A and the G1 to S transition.

Ting-Yuan Lee1, Tai-Yu Lai, Shin-Chih Lin, Cheng-Wei Wu, In-Fan Ni, Yu-San Yang, Liang-Yi Hung, Brian K Law, Chi-Wu Chiang.   

Abstract

Protein phosphatase 2A (PP2A) is a heterotrimeric enzyme consisting of a scaffold subunit (A), a catalytic subunit (C), and a variable regulatory subunit (B). The regulatory B subunits determine the substrate specificity and subcellular localization of the PP2A holoenzyme. Here, we demonstrate that the subcellular localization of the B56gamma3 regulatory subunit is regulated in a cell cycle-specific manner. Notably, B56gamma3 becomes enriched in the nucleus at the G(1)/S border and in S phase. The S phase-specific nuclear enrichment of B56gamma3 is accompanied by increases of nuclear A and C subunits and nuclear PP2A activity. Overexpression of B56gamma3 promotes nuclear localization of the A and C subunits, whereas silencing both B56gamma2 and B56gamma3 blocks the S phase-specific increase in the nuclear localization and activity of PP2A. In NIH3T3 cells, B56gamma3 overexpression reduces p27 phosphorylation at Thr-187, concomitantly elevates p27 protein levels, delays the G(1) to S transition, and retards cell proliferation. Consistently, knockdown of endogenous B56gamma3 expression reduces p27 protein levels and increases cell proliferation in HeLa cells. These findings demonstrate that the dynamic nuclear distribution of the B56gamma3 regulatory subunit controls nuclear PP2A activity, which regulates cell cycle controllers, such as p27, to restrain cell cycle progression, and may be responsible for the tumor suppressor function of PP2A.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448040      PMCID: PMC2898420          DOI: 10.1074/jbc.M109.094953

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.

Authors:  A Montagnoli; F Fiore; E Eytan; A C Carrano; G F Draetta; A Hershko; M Pagano
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

2.  Synchronization of cell populations in G1/S and G2/M phases of the cell cycle.

Authors:  Jane V Harper
Journal:  Methods Mol Biol       Date:  2005

3.  A B56 regulatory subunit of protein phosphatase 2A localizes to nuclear speckles in cardiomyocytes.

Authors:  Marisa S Gigena; Akihiko Ito; Hiroshi Nojima; Terry B Rogers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-03-18       Impact factor: 4.733

4.  Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.

Authors:  J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

5.  Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.

Authors:  H Morisaki; A Fujimoto; A Ando; Y Nagata; K Ikeda; M Nakanishi
Journal:  Biochem Biophys Res Commun       Date:  1997-11-17       Impact factor: 3.575

6.  Cyclin E-CDK2 is a regulator of p27Kip1.

Authors:  R J Sheaff; M Groudine; M Gordon; J M Roberts; B E Clurman
Journal:  Genes Dev       Date:  1997-06-01       Impact factor: 11.361

7.  Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle.

Authors:  S Coats; W M Flanagan; J Nourse; J M Roberts
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

8.  Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits.

Authors:  S Strack; J A Zaucha; F F Ebner; R J Colbran; B E Wadzinski
Journal:  J Comp Neurol       Date:  1998-03-23       Impact factor: 3.215

Review 9.  Mechanisms of receptor-mediated nuclear import and nuclear export.

Authors:  Lucy F Pemberton; Bryce M Paschal
Journal:  Traffic       Date:  2005-03       Impact factor: 6.215

10.  Identification of a novel protein phosphatase 2A regulatory subunit highly expressed in muscle.

Authors:  M A Tehrani; M C Mumby; C Kamibayashi
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

View more
  22 in total

1.  Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease.

Authors:  Samantha L Rosenthal; Xingbin Wang; F Yesim Demirci; Michael M Barmada; Mary Ganguli; Oscar L Lopez; M Ilyas Kamboh
Journal:  Am J Neurodegener Dis       Date:  2012

Review 2.  Protein phosphatase 2A: a target for anticancer therapy.

Authors:  Danilo Perrotti; Paolo Neviani
Journal:  Lancet Oncol       Date:  2013-05       Impact factor: 41.316

3.  The B55α-containing PP2A holoenzyme dephosphorylates FOXO1 in islet β-cells under oxidative stress.

Authors:  Ling Yan; Shuangli Guo; Marie Brault; Jamie Harmon; R Paul Robertson; Rizwan Hamid; Roland Stein; Elizabeth Yang
Journal:  Biochem J       Date:  2012-06-01       Impact factor: 3.857

Review 4.  Functions of B56-containing PP2As in major developmental and cancer signaling pathways.

Authors:  Jing Yang; Christopher Phiel
Journal:  Life Sci       Date:  2010-10-08       Impact factor: 5.037

5.  p27kip1 protein levels reflect a nexus of oncogenic signaling during cell transformation.

Authors:  Jeffrey P Miller; Nancy Yeh; Christoph P Hofstetter; Doruk Keskin; Andrew S Goldstein; Andrew Koff
Journal:  J Biol Chem       Date:  2012-04-17       Impact factor: 5.157

6.  Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1.

Authors:  H Liu; H Qiu; Y Song; Y Liu; H Wang; M Lu; M Deng; Y Gu; J Yin; K Luo; Z Zhang; X Jia; G Zheng; Z He
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

7.  Prognostic Impact of PPP2R5C Gene Expression in Adult Acute Myeloid Leukemia Patients with Normal Cytogenetics.

Authors:  Maha El Taweel; Rania M Gawdat; Rafaat Abdelfattah
Journal:  Indian J Hematol Blood Transfus       Date:  2019-06-08       Impact factor: 0.900

8.  Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling.

Authors:  Sokratis A Apostolidis; Thomas Rauen; Christian M Hedrich; George C Tsokos; José C Crispín
Journal:  J Biol Chem       Date:  2013-08-05       Impact factor: 5.157

9.  Quantitative fragmentome mapping reveals novel, domain-specific partners for the modular protein RepoMan (recruits PP1 onto mitotic chromatin at anaphase).

Authors:  Michèle Prévost; Delphine Chamousset; Isha Nasa; Emily Freele; Nick Morrice; Greg Moorhead; Laura Trinkle-Mulcahy
Journal:  Mol Cell Proteomics       Date:  2013-01-29       Impact factor: 5.911

10.  Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

Authors:  Yu Chen; Sichu Liu; Qi Shen; Xianfeng Zha; Haitao Zheng; Lijian Yang; Shaohua Chen; Xiuli Wu; Bo Li; Yangqiu Li
Journal:  DNA Cell Biol       Date:  2013-08-13       Impact factor: 3.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.